Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Serum cholesterol and mTOR inhibitors: surrogate biomarker or epiphenomenon?

Serum cholesterol and mTOR inhibitors: surrogate biomarker or epiphenomenon? Clin Cancer Res. 2012 Jun 01; 18(11):2999-3001.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.